Abstract
The anticancer activity of the ethanolic extract of Jasminum sambac against Dalton’s lymphoma ascites-induced lymphatic cancer in Swiss albino mice was investigated. The anticancer activity of J. sambac was studied against lymphoma using lipid profiles, biochemical parameters, and membrane-bound marker enzymes by standard procedures. A high-performance thin-layer chromatography fingerprinting analysis showed the presence of terpenoids and flavonoids. The levels of cholesterol, triglyceride, VLDL cholesterol, and LDL cholesterol were significantly decreased in tumor-induced mice, while HDL cholesterol showed increased levels compared with those profiles. On treatment with J. sambac, the levels were brought back to near normal. The albumin, creatinine, total protein, urea, and uric acid contents were also approaching normal values. There was s significant increase in the levels of ATPase in group II. These levels were brought back to normal upon plant extract treatment of mice. DNA fragmentation occurred in the tumor-induced group of tissue, and treatment with ethanolic extract reduced the DNA damage caused by lymphoma. Expression of lactate dehydrogenase (LDH) isoenzymes shows an increase in the levels of LDH-4 and LDH-5 in cancer-bearing animals which is brought back to near normal. Histopathological investigation showed normal sections of liver tissues in the treatment group. The results found in mice treated with ethanolic extract 100 mg kg−1 body weight quite promising and were comparable with the standard drug 5-fluorouracil. The statistically processed results support the conclusion that the ethanolic extract of J. sambac flower (100 mg kg−1) possesses a dose-dependent significant anticancer activity against lymphoma.
Similar content being viewed by others
References
Islam, M. S., Akhtar, M. M., Rahman, M. M., Rahman, M. A., Sarker, K. K., & Alam, M. F. (2009). Global Journal of Pharmacology, 3, 99–106.
Kalaiselvi, M., & Kalaivani, K. (2011). Pharmacologyonline, 1, 38–43.
Saha, D., & Tamrakar, A. (2011). Asian Journal of Research and Pharmacy Sciences, 1, 36–38.
Joshi, S.G. (2000). Oleaceae. In S.G. Joshi (Ed.), Medicinal plants (pp. 298–300). New Delhi: Oxford & IBH Publishing Co. Pvt. Ltd.
Shah, C. R., Suhagia, B. N., Shah, N. J., Patel, D. R., & Patel, N. M. (2008). Indian Journal of Pharmaceutical Sciences, 70, 251–255.
Zak, B. (1977). Clinical Chemistry, 23, 1201–1214.
Rice, E. W. (1970). In M. P. Roderic (Ed.), Triglycerides (“neutral fats”) in serum. Standard methods of clinical chemistry (Vol. 6, pp. 215–222). New York: Academic.
Warnick, G. R., Nguyen, T., & Albers, A. A. (1985). Clinical Chemistry, 31, 217.
Natelson, S., Scott, M., & Beffa, C. (1951). American Journal of Clinical Pathology, 21, 1153–1172.
Caraway, W. T. (1963). Uric acid. In D. Selingson (Ed.), Standard methods of clinical chemistry (Vol. 4, pp. 239–247). New York: Academic.
Owen, J. A., Iggo, J. B., Scandrett, F. J., & Stemart, I. P. (1954). Biochemistry Journal, 58, 426–437.
Wolfson, W. Q., Cohn, C. E., & Ichiba, F. (1948). Estimation of albumin–globulin ratio by Biuret methods. Clinical Practical Biochemistry. 4th Edn., Cbs Publishers, London.
Bonting, S. L. (1970). Sodium-potassium activated adenosine triphosphatase and calcium transport. In E. E. Bittar (Ed.), Membranes and ion transport (Vol. 1, pp. 739–769). New York: Wiley-Interscience.
Ohnishi, T., Suzuki, T., Suzuki, Y., & Ozawa, K. (1982). Biochemistry and Biophysics Acta, 684, 67–74.
Fiske, C. J., & Subbaroew, Y. (1925). Journal of Biological Chemistry, 66, 375–400.
Hyun, S. J., Yoon, M. Y., Kim, T. H., & Kim, J. H. (1997). Anticancer Research, 17, 225–229.
McKenzie, D., & Henderson, A. R. (1983). Clinical Chemistry, 29, 189–195.
Beckman, C. H. (2000). Physical and Molecular Plant Pathology, 57, 101–110.
Mariswamy, Y., Gnaraj, W. E., & Antonisamy, J. M. (2012). Asian Pacific Journal of Tropical Biomedical, S2, S8–S12.
Sasikumar, J. M., Jinu, U., & Shamna, R. (2009). European Journal of Biology Sciences, 1(2), 17–22.
Jagadeesh, M. C., Sreepriya, M., Bali, B., & Manjulakumari, D. (2009). African Journal of Biotechnology, 8, 4618–4622.
Hasugawa, T., & Kuroda, M. (1989). Japan Journal of Clinical Pathology, 37, 1020–1027.
Lins, K., Bezerra, D. P., Alves, A. P. N. N., Alencar, N. M. N., Lima, M. W., Torres, V. M., Farrias, W. R., Pessoa, C., De Moraes, M. O., & Costo-Lotufo, L. V. (2008). Journal of Applied Toxicology, 29, 20–26.
Anandan, R., Priya, M. S., Devi, K. P., & Devaki, T. (1999). Medical Science Research, 27, 127.
Mc Intyre, N., & Rosalki, S. (1992). Biochemical investigations in the management of liver disease. In J. Prieto, J. Rodes, & D. A. Shafriz (Eds.), Hepatobiliary diseases (pp. 39–71). Berlin: Springer.
Strasak, A. M., Rapp, K., Hilbe, W., Oberaigner, W., Ruttmann, E., Cocine, H., Diem, G., Pfeiffer, K. P., & Ulmer, H. (2007). Annals of Oncology, 18(11), 1893–1897.
Dongre, S. H., Badami, S., & Godavarthi, A. (2008). Phytotherapy Research, 22, 23–29.
Mohamed, H. A., El-Sayed, I. H., & Moawad, M. (2010). Natural Science, 8(6), 80–86.
Radak, Z., Taylor, A. W., Ohno, H., & Goto, S. (2001). Exercise Immunology Review, 7, 90–107.
Senthilnathan, P., Magesh, V., Padmavathi, R., & Sakthisekaran, D. (2002). Biomedical, 22, 83–88.
Wyllie, A. H. (1980). Nature, 284, 555–556.
Kerr, J. F., Wyllie, A. H., & Currie, A. R. (1972). British Journal of Cancer, 26, 239–257.
Wyllie, A. H., Kerr, J. F., & Currie, A. R. (1980). International Review of Cytology, 68, 251–306.
Sellins, K. S., & Cohen, J. J. (1987). Journal of Immunology, 139, 3199–3206.
Kaufmann, S. H. (1989). Cancer Research, 48, 5870–5878.
Yanagisawa-Shiota, F., Sakagami, H., Kuribayashi, N., Lida, M., Sakagami, T., & Takeda, M. (1995). Anti-cancer Research, 15, 259–265.
Koukourakis, M., Giatromanolaki, A., & Sivridis, E. (2003). Tumour Biology, 24, 199–202.
Fantin, V. R., St-Pierre, J., & Leder, P. (2006). Cancer Cell, 9, 425–434.
Jaroszewski, J. W., Kaplan, O., & Cohen, J. S. (1990). Cancer Research, 50, 6936–6943.
Coyle, T., Levante, S., Shetler, M., & Wintield, J. (1994). Journal of Neuro-Oncology, 19, 25–35.
Christofk, H. R., Heiden, M. G. V., Harris, M. H., Ramanathan, A., Gerszten, R. E., & Wei, R. (2008). Nature, 452, 230–233.
Trigun, S. K., Koiri, R. K., Mishra, L., Dubey, S., Singh, S., & Pandey, P. (2007). Current Enzyme Inhibition, 3, 243–253.
Prasad, S. B., & Giri, A. (1999). Cytologia (Tokyo), 64, 259–267.
Stefanini, M. (1985). Cancer, 55, 1931–1936.
Acknowledgments
We, the authors, are thankful to our Secretary and Joint Secretary of Kongunadu Arts and Science College, Coimbatore, Tamil Nadu, India for providing the facilities and encouragement.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kalaiselvi, M., Narmadha, R., Ragavendran, P. et al. Chemopreventive Effect and HPTLC Fingerprinting Analysis of Jasminum sambac (L.) Ait. Extract Against DLA-Induced Lymphoma in Experimental Animals. Appl Biochem Biotechnol 169, 1098–1108 (2013). https://doi.org/10.1007/s12010-012-0045-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-012-0045-6